Formulation and in vitro evaluation of xanthan gum or carbopol 934-based mucoadhesive patches, loaded with nicotine

AAPS PharmSciTech

Volumn 12, Issue 1, 2011, Pages 21-27

  Abu Huwaij, Rana ^a   Obaidat, Rana M ^b   Sweidan, Kamal ^c   Al Hiari, Yusuf ^c  

^a AL AHLIYYA AMMAN UNIVERSITY   (Jordan)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c UNIVERSITY OF JORDAN   (Jordan)

Author keywords

carbopol; FTIR; nicotine; Patches; Xanthan

Indexed keywords

ACID; BASE; CARBOPOL 934; ETHYL CELLULOSE; NICOTINE; POLYMER; XANTHAN;

ACID BASE BALANCE; ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; DRUG FORMULATION; DRUG RELEASE; FOURIER TRANSFORMATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SMOKING CESSATION;

ACRYLATES; ADHESIVENESS; ADHESIVES; ADMINISTRATION, BUCCAL; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; EXCIPIENTS; GANGLIONIC STIMULANTS; NICOTINE; POLYSACCHARIDES, BACTERIAL; SMOKING CESSATION;

EID: 79954425197     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9534-5     Document Type: Article

References (35)

1. D Yildiz 2004 Nicotine, its metabolism and an overview of its biological effects. (Review) Toxicon 43 619 632 15109883 10.1016/j.toxicon.2004.01.017 1:CAS:528:DC%2BD2cXjtlyhs70%3D (Pubitemid 38520766)
2. L Galanti 2008 Tobacco smoking cessation management: integrating varenicline in current practice Vasc Health Risk Manag. 4 4 837 845 19066000 1:CAS:528:DC%2BD1cXht1Shur%2FF PMCID: PMC2597768
3. KJ D'Orlando BS Fox 2004 Tolerability and pharmacokinetics of single and repeated doses of nicotine with the straw, a novel nicotine replacement product Nicotine Tob Res. 6 1 63 70 14982689 10.1080/14622200310001656876 (Pubitemid 38372475)
4. P Hajek R West J Foulds F Nilsson S Burrows A Meadow 1999 Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray and an inhaler Arch Intern Med. 159 2033 2038 10510989 10.1001/archinte.159.17.2033 1:CAS:528:DyaK1MXms12mtrw%3D (Pubitemid 29453591)
5. CR Park DL Munday 2002 Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy Int J Pharmaceut. 237 215 226 10.1016/S0378-5173(02)00041-8 1:CAS:528:DC%2BD38Xislyrtro%3D (Pubitemid 34326435)
6. J Hao P Heng 2003 Buccal delivery systems Drug Dev Ind Pharm. 29 8 821 832 14570303 10.1081/DDC-120024178 1:CAS:528:DC%2BD3sXntFamtLs%3D (Pubitemid 37203684)
7. A Shojaei 1998 Buccal mucosa as a route for systemic drug delivery: a review J Pharm Pharm Sci. 1 1 15 30 10942969 1:CAS:528:DyaK1MXks1Kgsrk%3D
8. J Xiang X Fang X Li 2002 Transbuccal delivery of 2′, 3′-dideoxycytidine: in vitro permeation study and histological investigation Int J Pharmaceut. 231 57 66 10.1016/S0378-5173(01)00865-1 1:CAS:528:DC%2BD3MXosVCltLg%3D (Pubitemid 33086819)
9. F Veuillez Y Kalia Y Jacques J Deshusses P Buri 2001 Factors and strategies for improving buccal absorption of peptides Eur J Pharm Biopharm. 51 93 109 11226816 10.1016/S0939-6411(00)00144-2 1:CAS:528:DC%2BD3MXhsVOhtbY%3D (Pubitemid 32162488)
10. Swarbrick A. Oral mucosal drug delivery. New York: Marcel Dekker; 1996.
11. S Shin J Kim I Oh 2000 Mucoadhesive and physicochemical characterization of carbopol-poloxamer gels containing triamcinolone acetonide Drug Dev Ind Pharm. 26 3 307 312 10738647 10.1081/DDC-100100358 1:CAS:528: DC%2BD3cXitVamtrc%3D (Pubitemid 30164745)
12. CR Park DL Munday 2004 Evaluation of selected Polysaccharide Excipients in buccoadhesive tablets for sustained release of nicotine Drug Dev Ind Pharm. 30 6 609 617 15285334 10.1081/DDC-120037492 1:CAS:528:DC%2BD2cXksFSgtrs%3D (Pubitemid 38924631)
13. JD Smart 2004 Recent developments in the use of bioadhesive systems for delivery of drugs to the oral cavity Crit Rev Ther Drug Carrier Syst. 21 319 344 15638469 10.1615/CritRevTherDrugCarrierSyst.v21.i4.20 1:CAS:528: DC%2BD2cXhtVShtLfE (Pubitemid 41647580)
14. JP Roubroeks R Andersson DI Mastromauro BE Christensen P Aman 2001 Molecular weight, structure and shape of oat (1∈→∈3), (1∈→∈4)-b-d-glucan fractions obtained by enzymatic degradation with (1∈→∈4)-b-d-glucan 4-glucanohydrolase from Trichoderma reesei Carbohydr Polym. 46 275 285 10.1016/S0144-8617(00)00329-5 1:CAS:528:DC%2BD3MXltlKktro%3D (Pubitemid 32704938)
15. B Perez-Marcos C Gutierrez JL Gomez-Amoza R Martinez-Pacheco C Souto A Concheiro 1991 Usefulness of certain varieties of Carbopol in the formulation of hydrophilic furosemide matrices Int J Pharmaceut. 67 2 113 121 10.1016/0378-5173(91)90423-L 1:CAS:528:DyaK3MXhslWhsr0%3D
16. J Lee J Park R Robinson 2000 Bioadhesive-based dosage forms; the next generation J Pharm Sci. 89 850 866 10861586 10.1002/1520-6017(200007)89: 7<850::AID-JPS2>3.0.CO;2-G 1:CAS:528:DC%2BD3cXlt1ahtbk%3D
17. J Hao WS Paul Heng 2003 Buccal delivery systems Drug Dev Ind Pharm. 29 8 821 832 14570303 10.1081/DDC-120024178 1:CAS:528:DC%2BD3sXntFamtLs%3D (Pubitemid 37203684)
18. RJ Majithiya PK Ghosh ML Umrethia RS Murthy 2006 Thermoreversible- mucoadhesive gel for nasal delivery of sumatriptan AAPS PharmSciTech 7 3 67 10.1208/pt070367 17025248 10.1208/pt070367 (Pubitemid 44270121)
19. R Abu-Huwaij S Assaf M Salem A Sallam 2007 Potential mucoadhesive dosage form of lidocaine hydrochloride: II. In vitro and in vivo evaluation Drug Dev Ind Pharm. 33 4 437 448 17523008 10.1080/03639040601150211 1:CAS:528: DC%2BD2sXls1Snt7g%3D (Pubitemid 46808779)
20. VM Patel BG Prajapati HV Patel KM Patel 2007 Mucoadhesive bilayer tablets of propranolol hydrochloride AAPS PharmSciTech 8 3 77 10.1208/pt0803077 1:CAS:528:DC%2BD2sXnslSls7o%3D
21. S Tamburic D Craig 1997 A comparison of different in vitro methods for measuring mucoadhesive performance Eur J Pharm Biopharm. 44 159 167 10.1016/S0939-6411(97)00073-8 1:CAS:528:DyaK2sXmvFOit70%3D (Pubitemid 28539151)
22. B Parodi E Russo G Caviglioli S Cafaggi G Bigbardi 1996 Development and characterization of a buccoadhesive dosage form of oxycodane hydrochloride Drug Dev Ind Pharm. 22 5 445 450 10.3109/03639049609069353 1:CAS:528: DyaK28XivVOis78%3D (Pubitemid 26171575)
23. J Emami J Varshosaz N Saljoughian 2008 Development and evaluation of controlledrelease buccoadhesive verapamil hydrochloride tablets DARU. 16 2 60 69 1:CAS:528:DC%2BD1cXhtV2qsrnO (Pubitemid 351877012)
24. KGH Desai TMP Kumar 2004 Preparation and evaluation of a novel buccal adhesive system AAP PharmSciTech 5 3 35
25. V Agarwal B Mishra 1999 Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine Drug Dev Ind Pharm. 25 6 701 709 10349555 10.1081/DDC-100102229 1:CAS:528:DyaK1MXjs12hsr0%3D (Pubitemid 29239399)
26. L Perioli V Ambrogi A Angelici M Ricci 2004 Development of mucoadhesive patches for buccal administration of ibuprofen J Control Release. 99 1 73 82 15342182 10.1016/j.jconrel.2004.06.005 1:CAS:528:DC%2BD2cXnt1Kjt78%3D (Pubitemid 39165735)
27. H Okamoto T Nakamori Y Arakawa K Iida K Danjo 2002 Development of polymer film dosage forms of lidocaine for buccal administration: II. Comparison of preparation methods J Pharm Sci. 91 11 2424 2432 12379928 10.1002/jps.10228 1:CAS:528:DC%2BD38XosF2htbg%3D (Pubitemid 35231206)
28. R Abu-Huwaij S Assaf M Salem A Sallam 2007 Potential mucoadhesive dosage form of lidocaine hydrochloride: I. Mucoadhesive and physicochemical characterization Drug Dev Ind Pharm. 33 8 855 864 17729103 10.1080/ 03639040701377516 1:CAS:528:DC%2BD2sXpsF2ksrc%3D (Pubitemid 47345853)
29. S Harding 2003 Mucoadhesive interactions Biochem Soc Trans. 31 5 1036 1042 14505475 10.1042/BST0311036 1:CAS:528:DC%2BD3sXnsVyjtL4%3D
30. J Ceulemans I Vinckier A Ludwig 2002 The use of xanthan gum in an ophthalmic liquid dosage form: rheological characterization of the interaction with mucin J Pharm Sci. 91 4 1117 1127 11948550 10.1002/jps.10106 1:CAS:528:DC%2BD38XjtFKhu7s%3D (Pubitemid 34640936)
31. J Liabot R Manzo D Allemandi 2002 Double layered mucoadhesive tablets containing nystatin AAPS PharmSciTech 3 3 22 10.1208/pt030322
32. N Salamat-Miller M Chittchang TP Johnston 2005 The use of mucoadhesive polymers in buccal drug delivery Adv Drug Deliv Rev. 57 1666 1691 16183164 10.1016/j.addr.2005.07.003 1:CAS:528:DC%2BD2MXhtFSisL7O (Pubitemid 41443474)
33. J Guo 1994 Bioadhesive polymer buccal patches for buprenorphine controlled delivery: formulation, in vitro adhesion and release properties Drug Dev Ind Pharm. 20 18 2809 2821 10.3109/03639049409042682 1:CAS:528: DyaK2cXmtFaruro%3D (Pubitemid 24319764)
34. RK Richardson SB Ross-Murphy 1987 Non-linear viscoelasticity of polysaccharide solutions. 2: xanthan polysaccharide solutions Int J Biol Macromol. 9 257 264 10.1016/0141-8130(87)90063-8 1:CAS:528:DyaL1cXhs1Orsbg%3D
35. C Lopez A Portero J Jato M Alonso 1998 Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery J Control Release 55 143 152 10.1016/S0168-3659(98)00044-3 (Pubitemid 28477605)